Innovative Air Purification CereneAir specializes in cutting-edge ozone-based air handling technology that inactivates pathogens including COVID-19, presenting a strong competitive edge in the clean air market especially within healthcare, commercial, and high-risk environments.

Recent Market Recognition The company has been awarded the Company of the Year in Air Purification Technology, enhancing its industry credibility and visibility, which can facilitate sales efforts to hospitals, institutions, and facilities seeking trusted air quality solutions.

Strategic Partnerships Recent collaborations with healthcare and service providers like MediGroup and Innovative Healthcare Solutions indicate an active sales pipeline in medical and institutional sectors, offering potential opportunities for expansion into related verticals.

Leadership Visibility The appointment of Susan Labadie as President, with extensive experience in sales, marketing, and operations in HVAC and related sectors, suggests a focus on market growth, channel development, and targeted outreach to major commercial and healthcare clients.

Growth Potential With a small but innovative product line and recent awards, CereneAir is positioned as a disruptor in the indoor air quality space, providing opportunities to scale its sales efforts across government, corporate, and healthcare markets seeking advanced pathogen mitigation solutions.